MSB 1.34% $1.51 mesoblast limited

Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-314

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 192 Posts.
    lightbulb Created with Sketch. 20
    MSB will have to reduce rates for sure for Covid-19 treatment... Manufacturing shouldn't be all that hard as they will have multiple pharmaceutical plants world wide offering their facilities, which are up and running and ready to go!

    I think we need to look at Covid as the Fast track train firing MSB quicker than expected to where it was going anyway!

    In 10 years time MSB may of well been a 10-50 dollar company anyway,

    Now with the Covid treatment in the gas tank we could be looking at 10-50 dollars in the next 2 years!



 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.